A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer

At present, there is no validated marker to identify the subpopulation of patients with advanced gastric cancer (AGC) who might benefit from neoadjuvant chemotherapy (NACT). In view of this clinical challenge, the identification of non-invasive biomarkers for efficacy prediction of NACT in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ting, Tang, Xiao-Huan, Gao, Xiang-Yu, Zhou, Yuan, Jin, Bo, Deng, Zi-Qian, Hu, Ying, Xing, Xiao-Fang, Li, Zi-Yu, Ji, Jia-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743536/
https://www.ncbi.nlm.nih.gov/pubmed/36510184
http://dx.doi.org/10.1186/s12943-022-01684-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743536/
https://www.ncbi.nlm.nih.gov/pubmed/36510184
http://dx.doi.org/10.1186/s12943-022-01684-9

Ejemplares similares